Skip to content

High Protein Oral Nutritional Support With Special Nutrients in Patients With Type 2 Diabetes and Foot Ulcer

Effekt af højproteindrik Med særligt Udvalgte næringsstoffer Til Mennesker Med Type 2 Diabetes og fodsår

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05464407
Enrollment
6
Registered
2022-07-19
Start date
2022-02-24
Completion date
2023-03-31
Last updated
2024-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healing Ulcer

Brief summary

To assess the supplement of a high protein oral nutritional supplement enriched with arginin, zink, vitamin c and antioxidants on the healing of foot ulcers in patients with type 2 diabetes mellitus

Detailed description

The intervention group receive 2 x ONS drink daily (total 2 x 200 kcal, 3 g arginin, 250 ml vitamin C, 38 mg vitamin e, 64 micr.g selenium, 9 mg zink)

Interventions

DIETARY_SUPPLEMENTCubitan

2 bottles of Cubitan daily, for 12 weeks.

Sponsors

Aalborg University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* type 2 diabetes with newly diagnosed foot ulcer * accept study participation

Exclusion criteria

* HbA1c \>90 mmol/L * cognitive challenges, fx dementia * history with known alcohol or drug abuse * allergy to milk or soya * home less * critical ischemia, distal blood pressure \<0.30 * EGFR \< 30 * dialysis or planned dialysis or patients with terminal kidney insufficiency

Design outcomes

Primary

MeasureTime frameDescription
foot ulcer area12 weeksReduction in ulcer area of the index ulcer, cm\^2(based on height and width) within 12 weeks
Foot ulcer healing12 weeksTime to complete healing

Secondary

MeasureTime frameDescription
HbA1c12 weeks and 6 monthsChange in HbA1c
Adverse events12 weeks and 6 monthsnumber of adverse events in relation to hypo- or hyperglycemia, amputations, kidney function
Body weight12 weeks and 6 monthschange in body weight
Improvement in Quality of life12 weeks and 6 monthsWorld Health Organisation - Five Well-Being Index (WHO 5). The total raw score, ranging from 0 to 25, is multiplied by 4 to give the final score, with 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.
Number of foot ulcers12 weeks and 6 monthsnumber of foot ulcers
Compliance to intervention12 weeksnumber of bottles ingested/bottles expected to ingest
Classifying/scoring of food ulcer12 weeks and 6 monthsUse of SINBAD (site-ischemia-neuropathy-bacterial infection-area-depth) score system. Minimum score 0, maximum score 6. Lower score is better outcome
Time to complete healing of foot ulcer6 monthsTime to complete healing of foot ulcer Time to complete heling of foot ulcer
Reduction in ulcer area6 monthsReduction in ulcer area of the index ulcer, cm\^2 (based on height and width)
Number of new foot ulcers12 weeks and 6 monthsCounting the number of new foot ulcers occuring after study inclusion
Depth foot ulcer12 weeksReduction in depth within 12 weeks
Accept of intervention12 weeksMeasured by Visual Analogue Scale, minimum score 1, maximum score 5. Lower score is better outcome

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026